Kaplan SA - Search Results

1

Pathologic Outcomes following Urethral Diverticulectomy in Women.

Laudano MA, Jamzadeh AE, Dunphy C, Lee RK, Robinson BD, Tyagi R, Kaplan SA, Te AE, Chughtai B. Laudano MA, et al. Among authors: kaplan sa. Adv Urol. 2014;2014:861940. doi: 10.1155/2014/861940. Epub 2014 Apr 17. Adv Urol. 2014. PMID: 24860605 Free PMC article.

2

PSA response to finasteride challenge in men with a serum PSA greater than 4 ng/ml and previous negative prostate biopsy: preliminary study.

Kaplan SA, Ghafar MA, Volpe MA, Lam JS, Fromer D, Te AE. Kaplan SA, et al. Urology. 2002 Sep;60(3):464-8. doi: 10.1016/s0090-4295(02)01760-0. Urology. 2002. PMID: 12350485 Clinical Trial.

3

A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome.

Kaplan SA, Volpe MA, Te AE. Kaplan SA, et al. J Urol. 2004 Jan;171(1):284-8. doi: 10.1097/01.ju.0000101487.83730.80. J Urol. 2004. PMID: 14665895 Clinical Trial.

4

High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates.

Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. Sandhu JS, et al. Among authors: kaplan sa. Urology. 2004 Dec;64(6):1155-9. doi: 10.1016/j.urology.2004.07.018. Urology. 2004. PMID: 15596189 Clinical Trial.

5

Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia.

Kaplan SA, Walmsley K, Te AE. Kaplan SA, et al. J Urol. 2005 Dec;174(6):2273-5. discussion 2275-6. doi: 10.1097/01.ju.0000181823.33224.a0. J Urol. 2005. PMID: 16280803

6

Photoselective laser vaporization prostatectomy in men receiving anticoagulants.

Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE. Sandhu JS, et al. Among authors: kaplan sa. J Endourol. 2005 Dec;19(10):1196-8. doi: 10.1089/end.2005.19.1196. J Endourol. 2005. PMID: 16359214

7

Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia.

Kaplan SA, Roehrborn CG, Dmochowski R, Rovner ES, Wang JT, Guan Z. Kaplan SA, et al. Urology. 2006 Aug;68(2):328-32. doi: 10.1016/j.urology.2006.03.006. Urology. 2006. PMID: 16904446 Clinical Trial.

8

Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.

Kaplan SA, Gonzalez RR, Te AE. Kaplan SA, et al. Eur Urol. 2007 Jun;51(6):1717-23. doi: 10.1016/j.eururo.2007.01.033. Epub 2007 Jan 16. Eur Urol. 2007. PMID: 17258855 Clinical Trial.

9

Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia.

Kaplan SA, Walmsley K, Te AE. Kaplan SA, et al. J Urol. 2008 May;179(5 Suppl):S82-5. doi: 10.1016/j.juro.2008.03.142. J Urol. 2008. PMID: 18405763

10

Urinary retention and post-void residual urine in men: separating truth from tradition.

Kaplan SA, Wein AJ, Staskin DR, Roehrborn CG, Steers WD. Kaplan SA, et al. J Urol. 2008 Jul;180(1):47-54. doi: 10.1016/j.juro.2008.03.027. Epub 2008 May 15. J Urol. 2008. PMID: 18485378 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,016 results

Search Page

Filters